RELATED WIKI ARTICLES
Back to NOVA
NovaMed Announces $80 Million Senior Secured Credit Facility

NovaMed, Inc. (Nasdaq: NOVA), a leading operator of ambulatory surgery centers in partnership with physicians, today announced that it has entered into an amendment to its credit agreement. The key terms of the amended credit agreement are as follows:

  • $80 million senior secured credit facility consisting of a $50 million revolving credit facility and a $30 million term loan facility. NovaMed has an option to increase the size of the revolving credit facility to $95 million under certain conditions.
  • The term of the credit facility has been extended to December 15, 2011. However, if NovaMed has repaid or refinanced its convertible senior subordinated notes prior to this date, the term will be extended to August 30, 2012.
  • NovaMed will be subject to a maximum total leverage ratio of 5.0 times initially, which will decrease to 4.75 times for the fiscal quarter ending December 31, 2009, 4.25 times for the fiscal quarter ending December 31, 2010 and 4.0 times for the fiscal quarter ending December 31, 2011 and thereafter.
  • NovaMed will be subject to a maximum senior leverage ratio of 2.5 times initially, which will decrease to 2.25 times for the fiscal quarter ending December 31, 2010 and thereafter.
  • Interest on borrowings under the facility is payable at an annual rate equal to LIBOR plus a range from 2.75% to 5.00% or Prime plus a range from 0.75% to 3.00%, depending on NovaMed’s total leverage ratio. At the company’s current total leverage ratio of 4.3 times, NovaMed’s interest rate on borrowings will be LIBOR plus 4.5% or Prime plus 2.5%.

National City Bank remains as agent, with Bank of America, TD Banknorth, Siemens Financial Services and First Merit Bank, as the other participating banks. NovaMed intends to continue to use its credit facility for acquisitions as well as general corporate purposes.

“In light of current credit market conditions, we are pleased with the terms of our amended credit facility,” commented Thomas S. Hall, Chairman, President and Chief Executive Officer of NovaMed.

NovaMed acquires, develops and operates ambulatory surgery centers (“ASCs”) in partnership with physicians and holds majority ownership interests in 37 surgery centers located in 19 states.

This press release contains forward-looking statements that relate to possible future events. These statements are based on management’s current expectations and are subject to risks and uncertainties, which could cause our actual results to differ materially from those expressed or implied in this press release. These risks and uncertainties include: the current economic recession and disruption in the financial markets; our current and future debt levels; our ability to access capital on a cost-effective basis to continue to successfully implement our growth strategy; reduced prices and reimbursement rates for surgical procedures; our ability to acquire, develop or manage a sufficient number of profitable surgical facilities; our ability to maintain successful relationships with the physicians who use our surgical facilities; our ability to grow and manage effectively our increasing number of surgical facilities; competition from other companies in the acquisition, development and operation of surgical facilities; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit our business operations, require us to incur significant expenditures or limit our ability to relocate our facilities if necessary. Readers are encouraged to review a more complete discussion of the factors affecting NovaMed’s business and prospects in its filings with the Securities and Exchange Commission, including the company’s 2008 Form 10-K filed on March 16, 2009. Readers should not place undue reliance on any forward-looking statements. Except as required by the federal securities laws, NovaMed undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
Back to NOVA
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki